Conventional Treatment of Chronic Hypoparathyroidism
Reference75 articles.
1. Sikjaer T, Rejnmark L, Rolighed L, Heickendorff L, Mosekilde L, the hypoparathyroid study group (2011) The effect of adding PTH (1–84) to conventional treatment of hypoparathyroidism – A randomized, placebo controlled study. J Bone Miner Res 26:2358–2370
2. Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L (2013) Cardiovascular and renal complications to postsurgical hypoparathyroidism: a Danish nationwide controlled historic follow-up study. J Bone Miner Res 28:2277–2285
3. Bagó AG, Dimitrov E, Saunders R, Seress L, Palkovits M, Usdin TB, Dobolyi A (2009) Parathyroid hormone 2 receptor and its endogenous ligand tuberoinfundibular peptide of 39 residues are concentrated in endocrine, viscerosensory and auditory brain regions in macaque and human. Neuroscience 162:128–147
4. Hadker N, Egan J, Sanders J, Lagast H, Clarke B (2014) Understanding the burden of illness associated with hypoparathyroidism reported among patients in the paradox study. Endocr Pract 20(7):671–679
5. Arlt W, Fremerey C, Callies F, Reincke M, Schneider P, Timmermann W, Allolio B (2002) Well-being, mood and calcium homeostasis in patients with hypoparathyroidism receiving standard treatment with calcium and vitamin D. Eur J Endocrinol 146:215–222